Largest Medical Devices Public Companies in Finland

Benchmark revenue and EBITDA valuation multiples for public comps like Revenio Group, Nexstim, Modulight, Biohit and Optomed.

Reset all filters
Finland
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for detecting diseases of significance to public health. Its ophthalmic diagnostic solutions includes intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, USA, and Others.
$13
-54%
$448M
$439M
3.6x
14.3x
Finland
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
$10
-40%
$72M
$70M
5.7x
35.3x
Finland
Modulight Corp is a biomedical company that designs and manufactures laser devices for the treatment of cancer, eye diseases, and for genetics. The company also manufactures products for other high-value-added applications such as flow cytometry, microscopy, semiconductors, quantum, and defense. The company provides biomedical lasers for oncology, genetics, and ophthalmology, supporting laser solutions like system integration service and laser design & manufacturing.
$1
-22%
$47M
$40M
5.1x
(120.4x)
Finland
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds and monoclonal antibodies and service laboratory operations.
$2
-32%
$37M
$35M
2.0x
9.6x
Finland
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company provides AI-based screening solutions to support diagnostic processes and early detection. It develops retinal imaging technology that is patented, clinically validated, and has approvals in all key markets, including CE, FDA and NMPA. The company's products are sold via various sales channels in over 60 countries. It has two reportable segments: Devices and Software. The majority of revenue is derived from the Software segment, which offers products for optimal management of various screening operations as well as IT solutions and services for storing, viewing and working with medical images. Geographically, it generates maximum revenue from Finland.
$2
-65%
$34M
$29M
1.5x
(5.5x)
Finland
Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. It has developed the following product lines: RemeOs and Activa. RemeOs is based on a high-performance magnesium alloy and hybrid composite, introducing absorbable materials for enhanced surgical outcomes. The RemeOs implants (RemeOs Screw Lag, RemeOs Screw Lag Solid, RemeOs Screw FT, etc.) are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The Activa implants (ActivaPin, ActivaNail, ActivaScrew, etc.) are based on fully absorbable biopolymer products that facilitate natural bone healing without requiring removal surgery.
$0
-75%
$34M
$20M
5.1x
(2.1x)
Median$2-47%$42M$38M4.3x3.7x

Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial